TOKYOMEDIJAPAN MEDICAL REFERENCE
⌕ Search databaseOfficial source · PMDA / MHLW
Rx · Reference only · no online purchase

Entresto (Sacubitril / valsartan)

Entresto / Sacubitril / valsartan. Mainly used for chronic heart failure; some strengths are also approved for hypertension.

PMDAproduct-level source2026-10label updated2026-10-05site verified
エンレスト錠50mg/100mg/200mg・粒状錠小児用12.5mg/31.25mg · 50 mg
Japanese product photo · 50 mg · ノバルティス ファーマ
Main useMainly used for chronic heart failure; some strengths are also approved for hypertension.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
Japan product name
エンレスト錠50mg/100mg/200mg・粒状錠小児用12.5mg/31.25mg
Brand
Entresto
Generic name
Sacubitril / valsartan
Japanese generic name
サクビトリルバルサルタン
Chinese name
沙库巴曲缬沙坦
Marketing authorization holder
ノバルティスファーマ株式会社
Strengths
50 mg / 100 mg / 200 mg; pediatric 12.5 mg / 31.25 mg
Dosage form
tablet / pediatric granule tablet
Therapeutic area
Cardiovascular
Regulatory status
Rx
Label updated
2026-10
TOKYO MEDI verified
2026-10-05
MEDICINE REFERENCE

Detailed product reference

Summaries refer to the listed Japanese product. Eligibility, adjustments and full risks depend on its label and strength; a clinician determines individual treatment.

01

Product overview

Entresto is an angiotensin-receptor/neprilysin inhibitor (ARNI). Japanese strength notation must not be equated with valsartan alone.

Read source section ↗
02

Mechanism of action

Sacubitril inhibits neprilysin; valsartan blocks angiotensin-II AT1 receptors.

Read source section ↗
03

Japanese indications & eligibility

Chronic heart failure uses include adult and pediatric formulations; hypertension approval is for 100/200 mg tablets.

Read source section ↗
04

Administration & dose differences

Heart failure usually starts at 50 mg twice daily and is titrated; hypertension usually uses 200 mg once daily.

Read source section ↗
05

Adverse effects & key risks

Watch for angioedema, hyperkalemia, renal dysfunction and hypotension.

Read source section ↗
06

Contraindications & special populations

Do not use with ACE inhibitors or within 36 hours of stopping them; other contraindications include angioedema history, severe hepatic impairment and pregnancy.

Read source section ↗
07

Drug interactions

Review ACE inhibitors, other ARBs, potassium-raising agents, NSAIDs and lithium.

Read source section ↗
08

Assessment & monitoring

Monitor blood pressure, creatinine, potassium, weight and symptoms, especially during titration.

Read source section ↗
09

Storage & handling

Store at room temperature and protect from moisture. The photo shows adult 50 mg tablets only.

Read source section ↗
10

Sources & verification

Product checked ·

Official source

These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.